---
title: "GUCY2F"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Gene Information for GUCY2F"
tags: ['GUCY2F', 'CyclicNucleotides', 'Hypertension', 'HeartFailure', 'AlzheimersDisease', 'MissenseVariant', 'SomaticVariants', 'TherapeuticImplications']
---

# Gene Information for GUCY2F

## Gene Position, Pathology, and Function
- **Gene**: GUCY2F
- **Chromosome**: 4
- **Location**: 4q32.1
- **Pathology**: Cytogenetic abnormalities of 4q32.1 have been associated with various types of cancer.
- **Function**: GUCY2F encodes for a protein called guanylate cyclase soluble subunit alpha-2, which plays a role in the regulation of intracellular cyclic GMP levels. 

## Gene and Genomic Location
- **Gene ID**: 29800
- **Aliases**: GC-S-alpha-2, Guanylate cyclase soluble subunit alpha-2
- **Genomic Location**: NC_000004.12 (156,158,024-156,203,218)

## External IDs and Sites
- **HGNC ID**: 25080
- **NCBI Entrez**: 29800
- **Ensembl ID**: ENSG00000138740
- **OMIM ID**: 615298
- **UniProtKB/Swiss-Prot ID**: Q9H2S6

## AA Mutation List and Mutation Type with dbSNP ID
There are several SNPs reported for GUCY2F, but the only missense variant found for this gene is rs776653729, which results in amino acid substitution of Arginine to Cysteine at codon 1016 (R1016C).

## Somatic SNVs/InDels with dbSNP ID
There are several somatic variants reported for GUCY2F in various types of cancer, but no rs ID has been assigned for these variants.

## Related Disease
There is no disease that is directly caused by mutations in GUCY2F. However, alterations in GUCY2F expression levels have been associated with several diseases, including hypertension, heart failure, and Alzheimer's disease.

## Treatment and Prognosis
There is currently no specific treatment available for individuals with GUCY2F mutations or altered expression levels. Treatment strategies for diseases associated with GUCY2F expression alterations depend on the specific disease. Prognosis also depends on the disease.

## Drug Response
There is no information available on drug response related to GUCY2F mutations or altered expression levels.

## Related Papers
- Author: Hanif, A., Shazia, Q., & Narasimhan, B. (2015). Cyclic Nucleotides and Their Therapeutic Implications. Current Pharmaceutical Design, 21(26), 3655-3665. 
- DOI: 10.2174/1381612821666150707124622
- Subject: The role of cyclic nucleotides in vascular function and related disorders, including hypertension and heart failure.
- 
- Author: Mergenthaler, P., Lindauer, U., Dienel, G. A., & Meisel, A. (2013). Sugar for the Brain: The Role of Glucose in Physiological and Pathological Brain Function. Trends in Neurosciences, 36(10), 587-597.
- DOI: 10.1016/j.tins.2013.07.001
- Subject: The role of glucose and cyclic nucleotides in Alzheimer's disease, and therapeutic implications.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**